A study for a 21 year old woman who takes Lamictal, Topamax - from FDA reports


378 females aged 21 (±5) who take the same drugs are studied. This is a personalized study for a 21 year old female patient who has Bipolar Ii Disorder. The study is created by eHealthMe based on reports from FDA.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our independent and original studies have been referenced on 400+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO.



On May, 15, 2018

378 females aged 21 (±5) who take Lamictal, Topamax are studied.


Number of reports submitted per year:

Lamictal, Topamax for a 21-year old woman.

Information of the patient in this study:

  • Age: 21
  • Gender: female
  • Conditions: Bipolar Ii Disorder
  • Drugs taken:
    • Lamictal (lamotrigine)
    • Topamax (topiramate)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Loss Of Appetite(lack of feeling to eat): 0 (0% of females aged 21 (±5) who take the drugs)
  • Bruxism(habitual grinding of the teeth, typically during sleep): 0 (0% of females aged 21 (±5) who take the drugs)
  • Agitation(state of anxiety or nervous excitement): 0 (0% of females aged 21 (±5) who take the drugs)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common drug interactions over time

< 1 month:
  1. Rashes (redness)
  2. Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)
  3. Lip swelling
  4. Blood lactate dehydrogenase increased
  5. C-reactive protein increased
1 - 6 months:
  1. Hallucination, visual (seeing things that aren't there)
  2. Depersonalisation
  3. Memory loss
  4. Sensory disturbance (sense disturbance)
  5. Abortion late (induced abortion after the 20th week)
6 - 12 months:
  1. Weight increased
  2. Dyskinesia (abnormality or impairment of voluntary movement)
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  4. Depression
  5. Completed suicide (act of taking one's own life)
1 - 2 years:
  1. Pain
  2. Fatigue (feeling of tiredness)
  3. Schizophrenia (a mental disorder characterized by a breakdown of thought processes)
  4. Nightmares (unpleasant dreams)
  5. Dizziness
2 - 5 years:
  1. Optic neuropathy (optic nerve damage)
  2. Vision blurred
  3. Hemianopia homonymous (visual field defect involving either the two right or the two left halves of the visual fields of both eyes)
  4. Cholecystitis chronic (long lasting infection of gallbladder)
  5. Hypokalemia (low potassium)
5 - 10 years:
  1. Seizures (abnormal excessive or synchronous neuronal activity in the brain)
  2. Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles)
  3. Urinary tract infection
  4. General physical health deterioration (weak health status)
  5. Premature labor
10+ years:
  1. Tracheostomy
  2. Blood potassium decreased
  3. Atelectasis (partial or complete collapse of the lung)
not specified:
  1. Drug ineffective
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  3. Fatigue (feeling of tiredness)
  4. Seizures (abnormal excessive or synchronous neuronal activity in the brain)
  5. Memory loss

Top conditions involved for these people *:

  1. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 19 people, 5.03%
  2. Birth Control : 18 people, 4.76%
  3. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 12 people, 3.17%
  4. Complex Partial Seizures (epileptic seizure): 11 people, 2.91%
  5. Depression : 11 people, 2.91%

Top co-used drugs for these people *:

  1. Clonazepam (39 people, 10.32%)
  2. Keppra (34 people, 8.99%)
  3. Fluoxetine (32 people, 8.47%)
  4. Vimpat (20 people, 5.29%)
  5. Tegretol (20 people, 5.29%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

You are not alone: Connect with people like you, or share your experience to help people like you.

What are the drugs?

What are the conditions?

What are the symtoms?

Could your drugs cause:

Could your conditions cause:



Related studies:

Related publications that referenced our studies

You may be interested in these posts

More posts for: Lamictal, Topamax, Bipolar ii disorder, Loss of appetite, Bruxism, Agitation

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.